论文标题
使用心率和血压检测COVID-19,从ARDS患者中学到的教训
Detection of COVID-19 Using Heart Rate and Blood Pressure: Lessons Learned from Patients with ARDS
论文作者
论文摘要
全世界受到了19冠纳韦病毒的影响。在这项研究时,美国受感染人数是全球最高的(790万感染)。在受感染人群中,被诊断出患有急性呼吸窘迫综合征(ARDS)的患者处于更多威胁生命的情况下,导致严重的呼吸系统衰竭。各种研究已经通过监测实验室指标和症状来研究Covid-19和ARDS的感染。不幸的是,这些方法仅限于临床环境,并且基于症状的方法被证明是无效的。相反,在无处不在的健康监测中,生命体征(例如心率)已用于早期检测不同的呼吸道疾病。我们认为,这种生物标志物在识别感染Covid-19的ARDS患者方面具有丰富的信息。在这项研究中,我们通过使用简单的生命体征来研究Covid-19对ARDS患者的行为。我们分析了与加利福尼亚大学学术卫生中心接纳的70名ARDS患者相关的血压和心率的长期日志(每个生命体征包含42506个样本),以区分Covid-19的受试者-1COVID-19。除了统计分析外,我们还开发了一个深神网络模型,以从纵向数据中提取特征。仅使用数据的前八天,我们的深度学习模型能够达到78.79%的准确性,以对感染Covid-19的ARDS患者的生命体征进行分类,而不是其他被诊断为患者的ARDS患者。
The world has been affected by COVID-19 coronavirus. At the time of this study, the number of infected people in the United States is the highest globally (7.9 million infections). Within the infected population, patients diagnosed with acute respiratory distress syndrome (ARDS) are in more life-threatening circumstances, resulting in severe respiratory system failure. Various studies have investigated the infections to COVID-19 and ARDS by monitoring laboratory metrics and symptoms. Unfortunately, these methods are merely limited to clinical settings, and symptom-based methods are shown to be ineffective. In contrast, vital signs (e.g., heart rate) have been utilized to early-detect different respiratory diseases in ubiquitous health monitoring. We posit that such biomarkers are informative in identifying ARDS patients infected with COVID-19. In this study, we investigate the behavior of COVID-19 on ARDS patients by utilizing simple vital signs. We analyze the long-term daily logs of blood pressure and heart rate associated with 70 ARDS patients admitted to five University of California academic health centers (containing 42506 samples for each vital sign) to distinguish subjects with COVID-19 positive and negative test results. In addition to the statistical analysis, we develop a deep neural network model to extract features from the longitudinal data. Using only the first eight days of the data, our deep learning model is able to achieve 78.79% accuracy to classify the vital signs of ARDS patients infected with COVID-19 versus other ARDS diagnosed patients.